yeah, it’s definitely good news. It was worrying me if they continued treatment on the SAD patients outside the trial and there was an adverse event that there would be a reaction from the FDA. Apparently they don’t like adverse events happening outside of the trial environment and can be a bit punitive. Now they are inside a trial I am pretty happy. And they can be counted for the safety and efficacy data.
I'm still hoping for some efficacy data in the next week or two. I remember Rohan saying in one of his presentations that if they had more patients show a response they would push the FDA for a faster timeline. An announcement like that with a good double whammy would definitely bring a smile.
I love the way this company keeps pushing to improve their timelines. I also like this the PYC hot copper threads just quietly. Everyone is very respectful of each others views.
- Forums
- ASX - By Stock
- Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study
yeah, it’s definitely good news. It was worrying me if they...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.010(5.71%) |
Mkt cap ! $863.2M |
Open | High | Low | Value | Volume |
18.0¢ | 18.5¢ | 17.5¢ | $614.8K | 3.415M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 1326249 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 0.180 |
6 | 369766 | 0.175 |
9 | 244804 | 0.170 |
6 | 235677 | 0.165 |
5 | 166258 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 1326249 | 12 |
0.190 | 567166 | 7 |
0.195 | 666578 | 7 |
0.200 | 1021264 | 7 |
0.205 | 936250 | 5 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |